Biomarkers in Immunotherapy of Melanoma
Conditions: Metastatic Melanoma; Immune Checkpoints Inhibitors; Gastrointestinal Microbiome (Bacterial and Viral); Exosomal mRNA Expression of PD-L1 and IFNγ Intervention: Drug: Immune checkpoint inhibitor Sponsors: Institute of Oncology Ljubljana; University of Ljubljana; Military Medical Academy, Belgrade, Serbia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer & Oncology | Gastroenterology | Immunotherapy | Melanoma | Research | Serbia Health | Skin Cancer